What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Toxin-antitoxin system, Genetics, vapBC, Microbiology and Gene.
His work carried out in the field of Toxin-antitoxin system brings together such families of science as Cell biology, Transcription and Protein biosynthesis.
His vapBC study combines topics from a wide range of disciplines, such as RNA and PIN domain.
As a part of the same scientific family, he mostly works in the field of RNA, focusing on Messenger RNA and, on occasion, VAPB.
The concepts of his Microbiology study are interwoven with issues in Model organism, Multidrug tolerance, Phenotype, Bacteria and Operon.
His biological study spans a wide range of topics, including Cell division, Locus, ParABS system and DNA replication.
His most cited work include:
- Prokaryotic toxin-antitoxin stress response loci. (871 citations)
- Toxin–antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes (740 citations)
- Unique type of plasmid maintenance function: postsegregational killing of plasmid-free cells. (494 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Plasmid, Genetics, Escherichia coli, Cell biology and Molecular biology.
His Plasmid study incorporates themes from Cell division and Nucleoid.
His Escherichia coli research is multidisciplinary, relying on both Toxin, Antitoxin and Microbiology.
His research in the fields of Toxin-antitoxin system overlaps with other disciplines such as RELB.
His Cell biology study integrates concerns from other disciplines, such as Amino acid, Protein biosynthesis, FtsZ, Cytoskeleton and Ribosome.
His Molecular biology research focuses on subjects like RNA, which are linked to Messenger RNA.
He most often published in these fields:
- Plasmid (40.22%)
- Genetics (39.11%)
- Escherichia coli (35.20%)
What were the highlights of his more recent work (between 2016-2021)?
- Escherichia coli (35.20%)
- Cell biology (27.37%)
- Antitoxin (18.44%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Escherichia coli, Cell biology, Antitoxin, Multidrug tolerance and Stringent response.
Escherichia coli is a primary field of his research addressed under Genetics.
Kenn Gerdes has researched Cell biology in several fields, including Amino acid and Biosynthesis.
His Antitoxin study combines topics in areas such as Plasmid, Promoter, Operon and Molecular biology.
His Toxin-antitoxin system study, which is part of a larger body of work in Plasmid, is frequently linked to Evolutionary dynamics, bridging the gap between disciplines.
As part of the same scientific family, Kenn Gerdes usually focuses on Multidrug tolerance, concentrating on Translation and intersecting with Proteome, DNA replication and Metabolism.
Between 2016 and 2021, his most popular works were:
- Toxins, Targets, and Triggers: An Overview of Toxin-Antitoxin Biology (238 citations)
- Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells. (120 citations)
- Novel (p)ppGpp Binding and Metabolizing Proteins of Escherichia coli (75 citations)
In his most recent research, the most cited papers focused on:
Kenn Gerdes mainly investigates Escherichia coli, Antitoxin, Cell biology, Toxin and Multidrug tolerance.
His Escherichia coli study focuses on Biochemistry and Gene.
His studies in Antitoxin integrate themes in fields like Transcription, Operon, DNA replication and Enzyme.
His Cell biology research integrates issues from SeqA protein domain, Phage shock and Ribosomal protein.
His research integrates issues of Derepression, Psychological repression, Molecular biology, Promoter and NAD+ kinase in his study of Toxin.
His Multidrug tolerance study is concerned with Genetics in general.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
